These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


500 related items for PubMed ID: 30144082

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Use of supplemental anti-HBc testing of donors showing non-discriminating reactive results in multiplex nucleic acid testing.
    Kang JW, Seo JH, Youn KW, Seo YI, Huh K, Choi GR, Min HK, Oh DJ, Jo HJ, Kim JN.
    Vox Sang; 2017 Oct; 112(7):622-627. PubMed ID: 28891069
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection.
    Romanò L, Velati C, Cambiè G, Fomiatti L, Galli C, Zanetti AR, SIMTI study group for HBV infection among first-time blood donors.
    Blood Transfus; 2013 Apr; 11(2):281-8. PubMed ID: 23399361
    [Abstract] [Full Text] [Related]

  • 48. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A, Mafi-Nejad A, Tabei SZ, Lankarani KB, Torab A, Moaddeb A.
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [Abstract] [Full Text] [Related]

  • 49. Prevalence of Hepatitis B Virus (HBV) Among Blood Donors in Eastern Saudi Arabia: Results From a Five-Year Retrospective Study of HBV Seromarkers.
    Alzahrani FM, Muzaheed, Shaikh SS, Alomar AI, Acharya S, Elhadi N.
    Ann Lab Med; 2019 Jan; 39(1):81-85. PubMed ID: 30215234
    [Abstract] [Full Text] [Related]

  • 50. Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan.
    Taira R, Satake M, Momose S, Hino S, Suzuki Y, Murokawa H, Uchida S, Tadokoro K.
    Transfusion; 2013 Jul; 53(7):1393-404. PubMed ID: 23033944
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Comprehensive analysis of hepatitis B virus infections in blood donors in southern China that are surface antigen positive but nucleic acid testing negative.
    Ye X, Li T, Zhang R, Liu H, Zeng J, Hong W, Lu L, Zhu W, Li S, Xu M, Wu S, Chen L.
    Transfusion; 2020 Jul; 60(7):1476-1482. PubMed ID: 32358842
    [Abstract] [Full Text] [Related]

  • 53. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
    Laperche S, Maniez M, Barlet V, El Ghouzzi MH, Le Vacon F, Levayer T, Lunel F, Morel P, Mouillot L, Piquet Y, Pillonel J, Transfusion-Transmissible Agents Working Group, French National Society of Blood Transfusion.
    Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
    [Abstract] [Full Text] [Related]

  • 54. Anti-HBc and hepatitis B virus DNA among HBsAg-negative blood donors from the main central blood bank units in Eastern Libya.
    El-Nabi SH, El-Garawani I, Ismail F, Abdelsameea E.
    Transfus Med; 2020 Oct; 30(5):401-405. PubMed ID: 32894893
    [Abstract] [Full Text] [Related]

  • 55. Fifteen years of Nucleic Acid Testing in France: Results and lessons.
    Laperche S, Tiberghien P, Roche-Longin C, Pillonel J.
    Transfus Clin Biol; 2017 Sep; 24(3):182-188. PubMed ID: 28709845
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E.
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [Abstract] [Full Text] [Related]

  • 60. Marked reduction in the incidence of transfusion-transmitted hepatitis B virus infection after the introduction of antibody to hepatitis B core antigen and individual donation nucleic acid amplification screening in Japan.
    Tanaka A, Yamagishi N, Hasegawa T, Miyakawa K, Goto N, Matsubayashi K, Satake M.
    Transfusion; 2023 Nov; 63(11):2083-2097. PubMed ID: 37767806
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 25.